Genscript Biotech Corp
HKEX:1548
Genscript Biotech Corp
HKEX:1548
Price:
10.32 HKD
-0.96%
Market Closed
Updated:
May 29, 2024
Genscript Biotech Corp
Cash from Investing Activities
|
Genscript Biotech Corp
Cash from Investing Activities Peer Comparison
Comparables:
603259
300759
2269
300347
M
688114
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Genscript Biotech Corp
HKEX:1548
|
Cash from Investing Activities
-$357.7m
|
CAGR 3-Years
-53%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Cash from Investing Activities
-¥7.2B
|
CAGR 3-Years
6%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Cash from Investing Activities
-¥2.8B
|
CAGR 3-Years
12%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
N/A
|
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Cash from Investing Activities
-¥3.2B
|
CAGR 3-Years
24%
|
CAGR 5-Years
-51%
|
CAGR 10-Years
N/A
|
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Cash from Investing Activities
-¥1.1B
|
CAGR 3-Years
27%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
-21%
|
|
M
|
MGI Tech Co Ltd
SSE:688114
|
Cash from Investing Activities
-¥1B
|
CAGR 3-Years
8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Genscript Biotech Corp's Cash from Investing Activities?
Cash from Investing Activities
-357.7m
USD
-357.7m
USD
Based on the financial report for Dec 31, 2023, Genscript Biotech Corp's Cash from Investing Activities amounts to -357.7m USD.
What is Genscript Biotech Corp's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-15%
-15%
Over the last year, the Cash from Investing Activities growth was 19%. The average annual Cash from Investing Activities growth rates for Genscript Biotech Corp have been -53% over the past three years , -15% over the past five years .
You don't have any saved screeners yet
